Profile of Nivolumab in the Treatment of Resected Esophageal Squamous Cell Carcinoma: A Review of the Clinical Data

Yuntae Kim,1,2 Shun Yamamoto,1 Ken Kato1 1Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 2Department of Gastroenterology, St. Luke International Hospital, Tokyo, JapanCorrespondence: Ken Kato, Department of Head and Neck, Esophageal Medical O...

Full description

Bibliographic Details
Main Authors: Kim Y, Yamamoto S, Kato K
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/profile-of-nivolumab-in-the-treatment-of-resected-esophageal-squamous--peer-reviewed-fulltext-article-CMAR

Similar Items